2024-02-13 14:45:17 ET
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)
Q4 2023 Earnings Call
Feb 13, 2024 , 8:00 a.m. ET
Operator
For further details see:
Biogen (BIIB) Q4 2023 Earnings Call Transcript2024-02-13 14:45:17 ET
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)
Q4 2023 Earnings Call
Feb 13, 2024 , 8:00 a.m. ET
Operator
For further details see:
Biogen (BIIB) Q4 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Thursday, Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Biogen Inc (NASDAQ:BIIB) decided to terminate the development of BII...
Development of BIIB105, an investigational antisense oligonucleotide for amyotrophic lateral sclerosis (ALS), will be discontinued based on data from the Phase 1/2 ALSpire study Biogen and Ionis continue their long-standing commitment to developing therapies for ALS given the devastating impa...
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status PR Newswire TOKYO and CAMBRIDGE, Mass. , May 14, 2024...